Rrad-flox Mouse
一般名
Rrad-flox
製品ID
S-CKO-12098
背景情報
C57BL/6JCya
系統ID
CKOCMP-56437-Rrad-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Rrad-flox Mouse(カタログ番号S-CKO-12098)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Rrad-flox
系統ID
CKOCMP-56437-Rrad-B6J-VA
遺伝子名
製品ID
S-CKO-12098
遺伝子別名
Rad, REM3
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000034351
NCBIトランスクリプトID
NM_019662
ターゲット領域
Exon 3~5
有効領域の大きさ
~1.8 kb
遺伝子研究の概要
RRAD, short for Ras-related associated with diabetes, is a member of the Ras-related GTPase superfamily. Primarily a cytosolic protein that activates in the plasma membrane, it is highly expressed in type 2 diabetes patients and serves as a biomarker for congestive heart failure. RRAD is involved in multiple cellular activities such as cell division, motility, apoptosis, and energy metabolism, by modulating tumor-related gene expression and interacting with downstream effectors [1].
In cancer, RRAD shows dual roles. In gastric and colorectal cancer, its inhibition via siRNA/shRNA led to decreased tumor cell proliferation in vitro and in vivo, along with reduced cell invasion, decreased EMT markers, angiogenesis, and associated proteins like VEGF and ANGP2, suggesting it could be a therapeutic target [2]. In papillary thyroid cancer, the NEAT1_2/RRAD/EHF positive feedback loop facilitated aerobic glycolysis [3]. In hepatocellular carcinoma, RRAD suppressed the Warburg effect by downregulating ACTG1, reducing cell proliferation, arresting the cell cycle, and increasing apoptosis [4]. In lung cancer, it inhibited the Warburg effect through negative regulation of the NF-κB signaling [5]. In contrast, in malignant glioblastoma, RRAD promoted EGFR-mediated STAT3 activation and temozolomide resistance [6]. In pancreatic cancer, SETD8 inhibited ferroptosis by inhibiting RRAD expression [7]. In oral squamous cell carcinoma, downregulation of RRAD in the tumor margin enhanced energy metabolism and tumor progression [8]. Also, RRAD was identified as a marker and negative regulator of cellular senescence, with its up-regulation countering cellular senescence by reducing reactive oxygen species levels [9].
In conclusion, RRAD is a multifunctional gene involved in various biological processes and diseases, especially cancer. Its dual role as either an oncogene or tumor suppressor depending on the cancer type highlights its complexity. Studies on RRAD using gene-knockout or conditional-knockout models (although not specifically detailed in the given references) could potentially further clarify its role in these biological processes and disease conditions, providing insights for targeted therapies.
References:
1. Sun, Zhangyue, Li, Yongkang, Tan, Xiaolu, Xu, Liyan, Long, Lin. 2023. Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer. In Biomolecules, 13, . doi:10.3390/biom13030477. https://pubmed.ncbi.nlm.nih.gov/36979412/
2. Kim, Hee Kyung, Lee, Inkyoung, Kim, Seung Tae, Park, Joon Oh, Kang, Won Ki. 2019. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis. In Scientific reports, 9, 19439. doi:10.1038/s41598-019-55767-7. https://pubmed.ncbi.nlm.nih.gov/31857616/
3. Sun, Wei, Wang, Zhiyuan, Qin, Yuan, He, Liang, Zhang, Hao. . NEAT1_2/RRAD/EHF Positive Feedback Loop Facilitates Aerobic Glycolysis in Papillary Thyroid Cancer Cells. In Endocrinology, 164, . doi:10.1210/endocr/bqad085. https://pubmed.ncbi.nlm.nih.gov/37279586/
4. Yan, Yingcai, Xu, Hao, Zhang, Linshi, Ge, Wenhao, Wang, Weilin. 2019. RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma. In OncoTargets and therapy, 12, 1691-1703. doi:10.2147/OTT.S197844. https://pubmed.ncbi.nlm.nih.gov/30881024/
5. Liu, Juan, Zhang, Cen, Wu, Rui, Yang, Bo, Feng, Zhaohui. . RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling. In Oncotarget, 6, 14982-92. doi:. https://pubmed.ncbi.nlm.nih.gov/25893381/
6. Yeom, Seon-Yong, Nam, Do-Hyun, Park, Chaehwa. 2014. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. In Molecular cancer therapeutics, 13, 3049-61. doi:10.1158/1535-7163.MCT-14-0244. https://pubmed.ncbi.nlm.nih.gov/25313011/
7. Lu, Zekun, Hu, Qiangsheng, Qin, Yi, Xu, Xiaowu, Chen, Xuemin. 2023. SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD. In Cancer cell international, 23, 50. doi:10.1186/s12935-023-02899-6. https://pubmed.ncbi.nlm.nih.gov/36934248/
8. Cheng, Aoming, Xu, Qiaoshi, Li, Bo, Han, Zhengxue, Feng, Zhien. 2024. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma. In Cell death & disease, 15, 376. doi:10.1038/s41419-024-06759-7. https://pubmed.ncbi.nlm.nih.gov/38811531/
9. Wei, Zhao, Guo, Haiyang, Qin, Junchao, Gong, Yaoqin, Shao, Changshun. 2018. Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence. In Free radical biology & medicine, 130, 267-277. doi:10.1016/j.freeradbiomed.2018.10.457. https://pubmed.ncbi.nlm.nih.gov/30391675/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
